跳至主要内容
临床试验/JPRN-UMIN000038826
JPRN-UMIN000038826已完成未知

Which is the better treatment for lung metastases from giant cell tumor of bone, metastasectomy or non-metastasectomy? A systematic review - Lung metastases from GCTB: A systematic review

ara Medical University0 个研究点目标入组 138 人开始时间: 2019年12月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
138

研究概览

简要总结

The mortality of the patients was similar in the metastasectomy and the nonmetastasectomy groups; the proportion of patients in the metastasectomy group who died of disease was 7.1% (6 of 85) compared with 17.0% (9 of 53) in the non-metastasectomy group; the overall pooled OR was 0.64 (95% CI, 0.24-1.68; P=.360), and the heterogeneity I2 was 0% (Figure A, available in the online version of the article).

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The patients who had inoperable lung metastases and were treated with observation, chemotherapy, or radiotherapy, were excluded.We excluded studies without a comparison group, those without a report of tumor-related death, isolated case reports or case series including fewer than five patients and non-English and non-Japanese language abstracts. We did not place any restrictions on the date of publication.

研究者

发起方
ara Medical University

相似试验